2019年8月7日

廣受好評的係統交易者傑伊·福伊爾斯坦新聞分享這篇文章提供的芝加哥,8月7日2019 /傑伊·福伊爾斯坦從一個高度讚譽的係統交易者擁有超過三十年quant-trader和組合工程師,回顧一遍,收到“十大”為他的基金2019年6月績效獎BarclayHedge + 8.9%的回歸。福伊爾斯坦,他推出了他的基金,三叉戟期貨基金LP(“中醫”、“三叉戟”)今年1月,已報告五個六個月的積極和年回報率為16%,到2019年6月30日。過去的表現並不一定代表將來的結果。中醫是建立“最耐用,差異化和多樣化投資組合的全球宏觀空間。的主要優勢是能夠識別風險重新定價的機製和利潤在時代的變化風險承受的資產。而其他係統的全球宏觀和CTA組合在過去的十年裏,中醫,這隻交易期貨,是為了銷售在2008後交易時代,”Jay評論說。“我們先進的量化模型能夠確定風險製度,決定我們對風險資產的欲望,一直執行在這困難的關鍵年。2009年股市觸底時,09崩潰後,中醫模型不僅利用了崩潰,他們也足夠靈活地實現平衡和利潤當股票改變課程,和反彈,”他繼續說。福伊爾斯坦,他的血統和個人成功僅提供信譽對中醫的投資者(他創立,是氙Capital Management的首席執行官報告+ 43%的回報在2008年崩潰,他“首席交易員”期貨雜誌和他在2009年2月的文章。他還帶領氙經過眾多表演獎項,包括IAIR獎在2011年和2012年作為美國高級管理期貨公司。 He later sold Xenon to Manning and Napier, a publicly traded Asset Manager and spent two years with them before leaving to begin working on the development of TCM). It was this experience and Jay's thesis for the new fund that led two Chicago-based family offices (D'Orazio Capital and G-Bar LP) in their decision to partner with him. Matt Gray, President of G-Bar LP, one of Chicago's largest and most profitable trading houses, shared, "Our firm reviewed well in-excess of 1,000 proposals for new funds and trading strategies over the years and TCM is the first one we elected to support. What Jay designed is not only unique, but to be candid, makes logical sense. We strongly believe the market will be interested in learning about the opportunity TCM provides." "The goal of TCM was to create a differentiated strategy from its peers in an opportunistic way; as an example, TCM exploits trends if present, but if choppy, as they have been since 2008, our portfolio re-balances and focuses on the risk regime aspects, rather than trends. So, at times, TCM has negative correlations with peers and at other times, strong correlations, depending on the profit opportunity. Overall, the daily correlation to the CTA indices, thus far, is under 0.4 and the correlation to the stock-market is zero," Jay stated. Matt Gray commented, "We have capacity in excess of $1 billion, but our goal for TCM is rather simple: maintain performance as we grow and considering we trade the most liquid markets in the world, we should have no problem doing just that. " As for a final thought from Feuerstein, "This is a culmination of all that I have done over the past 30 years. It is my legacy, and I am so very proud and excited to bring the opportunities of TCM to the market." About Trident Capital Management LLC Trident Capital Management LLC ("TCM") is a fully diversified Systematic Global-Macro strategy, trading all four asset classes: stocks, bonds, commodities, and currencies. TCM earns its profit on the re-pricing of those asset classes during changes in economic-cycles, as well as risk-regimes. For more information about TCM, please visit www.tcmff.com , or call Matthew Rawlings, Partner in charge of Investor Relations at (312) 948-8938. Past performance is not necessarily indicative of future results. Matthew Rawlings